PMC:7172841 / 1571-1659
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T22 | 46-54 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T23 | 46-50 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T13 | 3-5 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 0-88 | Sentence | denotes | • IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T10 | 68-88 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T54 | 3-7 | PR:000001393 | denotes | IL-6 |
| T55 | 16-27 | DG_35 | denotes | Tocilizumab |
| T56 | 46-56 | SP_7 | denotes | SARS-CoV-2 |
| T57 | 75-88 | GO:0065007 | denotes | dysregulation |
| T288 | 3-7 | PR:000001393 | denotes | IL-6 |
| T45776 | 16-27 | DG_35 | denotes | Tocilizumab |
| T71931 | 46-56 | SP_7 | denotes | SARS-CoV-2 |
| T97850 | 75-88 | GO:0065007 | denotes | dysregulation |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 85 | 3-7 | Gene | denotes | IL-6 | Gene:3569 |
| 86 | 46-56 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 87 | 16-27 | Chemical | denotes | Tocilizumab | MESH:C502936 |